Cargando…

Single-Cell Sequencing of Malignant Ascites Reveals Transcriptomic Remodeling of the Tumor Microenvironment during the Progression of Epithelial Ovarian Cancer

Epithelial ovarian cancer (EOC) is the main cause of mortality among gynecological malignancies worldwide. Although patients with EOC undergo aggregate treatment, the prognosis is often poor. Peritoneal malignant ascites is a distinguishable clinical feature in EOC patients and plays a pivotal role...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yiqun, Wang, Wenjie, Wang, Danyun, Zhang, Liuchao, Wang, Xizhi, He, Jia, Cao, Lei, Li, Kang, Xie, Hongyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9778425/ https://www.ncbi.nlm.nih.gov/pubmed/36553542 http://dx.doi.org/10.3390/genes13122276

Ejemplares similares

Identifying Potential Markers for Monitoring Progression to Ovarian Cancer Using Plasma Label-free Proteomics
por: Wang, Wenjie, et al.
Publicado: (2021)

Oncolytic adenovirus inhibits malignant ascites of advanced ovarian cancer by reprogramming the ascitic immune microenvironment
por: Shi, Gang, et al.
Publicado: (2021)

Ascites Volumes and the Ovarian Cancer Microenvironment
por: Penet, Marie-France, et al.
Publicado: (2018)

Dynamic Changes in Myofibroblasts Affect the Carcinogenesis and Prognosis of Bladder Cancer Associated With Tumor Microenvironment Remodeling
por: Du, YiHeng, et al.
Publicado: (2022)

Immune Tumor Microenvironment in Ovarian Cancer Ascites
por: Almeida-Nunes, Diana Luísa, et al.
Publicado: (2022)

The Epithelial to Mesenchymal Transition Related Gene Calumenin Is an Adverse Prognostic Factor of Bladder Cancer Correlated With Tumor Microenvironment Remodeling, Gene Mutation, and Ferroptosis
por: Du, YiHeng, et al.
Publicado: (2021)

Single-cell analyses implicate ascites in remodeling the ecosystems of primary and metastatic tumors in ovarian cancer
por: Zheng, Xiaocui, et al.
Publicado: (2023)

Corrigendum: The epithelial to mesenchymal transition related gene calumenin is an adverse prognostic factor of bladder cancer correlated with tumor microenvironment remodeling, gene mutation, and ferroptosis
por: Du, YiHeng, et al.
Publicado: (2023)

The Epithelial-Mesenchymal Transition Initiated by Malignant Ascites Underlies the Transmesothelial Invasion of Ovarian Cancer Cells
por: Pakuła, Martyna, et al.
Publicado: (2019)

Mediation Analysis Reveals Potential Biological Mechanism of Ascites Influencing Recurrence in Patients with Epithelial Ovarian Cancer
por: Yang, Chunyan, et al.
Publicado: (2020)

The Proangiogenic Capabilities of Malignant Ascites Generated by Aggressive Ovarian Tumors
por: Mikuła-Pietrasik, Justyna, et al.
Publicado: (2017)

Tumor cell-fibroblast heterotypic aggregates in malignant ascites of patients with ovarian cancer
por: Han, Qing, et al.
Publicado: (2019)

Hemodynamic Consequences of Malignant Ascites in Epithelial Ovarian Cancer Surgery(∗): A Prospective Substudy of a Randomized Controlled Trial
por: Hunsicker, Oliver, et al.
Publicado: (2015)

Emerging treatment options for management of malignant ascites in patients with ovarian cancer
por: Eskander, Ramez N, et al.
Publicado: (2012)

Malignant ascites: a source of therapeutic protein against ovarian cancer?
por: Ribaux, Pascale, et al.
Publicado: (2019)

Improved migration of tumor ascites lymphocytes to ovarian cancer microenvironment by CXCR2 transduction
por: Idorn, Manja, et al.
Publicado: (2017)

Ascites-induced compression alters the peritoneal microenvironment and promotes metastatic success in ovarian cancer
por: Asem, Marwa, et al.
Publicado: (2020)

Remodeling tumor microenvironment by liposomal codelivery of DMXAA and simvastatin inhibits malignant melanoma progression
por: Rauca, Valentin-Florian, et al.
Publicado: (2021)

Transcriptomic Study on the Lungs of Broilers with Ascites Syndrome
por: Guo, Dongqing, et al.
Publicado: (2023)

Screening and Identification of Biomarkers in Ascites Related to Intrinsic Chemoresistance of Serous Epithelial Ovarian Cancers
por: Huang, He, et al.
Publicado: (2012)

Senescent epithelial cells remodel the microenvironment for the progression of oral submucous fibrosis through secreting TGF-β1
por: Wang, Zijia, et al.
Publicado: (2023)

Inflammation-regulating factors in ascites as predictive biomarkers of drug resistance and progression-free survival in serous epithelial ovarian cancers
por: Lane, Denis, et al.
Publicado: (2015)

Exosomes in ovarian cancer ascites promote epithelial–mesenchymal transition of ovarian cancer cells by delivery of miR-6780b-5p
por: Cai, Jing, et al.
Publicado: (2021)

Management of non-ovarian cancer malignant ascites through indwelling catheter drainage
por: Gu, Xiaoli, et al.
Publicado: (2016)

Activation of LXRɑ/β by cholesterol in malignant ascites promotes chemoresistance in ovarian cancer
por: Kim, Soochi, et al.
Publicado: (2018)

Chemotherapy sensitivity testing on ovarian cancer cells isolated from malignant ascites
por: den Ouden, Judith E., et al.
Publicado: (2020)

Malignant Ascites Promote Adhesion of Ovarian Cancer Cells to Peritoneal Mesothelium and Fibroblasts
por: Uruski, Paweł, et al.
Publicado: (2021)

Cisplatin remodels the tumor immune microenvironment via the transcription factor EB in ovarian cancer
por: Liu, Wei, et al.
Publicado: (2021)

Quantum dot-based multiplexed imaging in malignant ascites: a new model for malignant ascites classification
por: Zeng, Wei-Juan, et al.
Publicado: (2015)

Stromal–Epithelial Crosstalk Provides a Suitable Microenvironment for the Progression of Ovarian Cancer Cells in Vitro
por: Fu, Shilong, et al.
Publicado: (2013)

Ovarian hyperstimulation syndrome and pregnancy luteoma mimicking malignant ascites: a rare case report
por: Chen, Jing, et al.
Publicado: (2023)

Assessment of cells in the ascitic fluid of women with ovarian hyperstimulation syndrome: the clinical implications for subsequent ovarian malignancy
por: Hatzipetros, Ioannis, et al.
Publicado: (2013)

Peritoneal inflammation – A microenvironment for Epithelial Ovarian Cancer (EOC)
por: Freedman, Ralph S, et al.
Publicado: (2004)

Interferon-γ secreted by recruited Th1 cells in peritoneal cavity inhibits the formation of malignant ascites
por: Liu, Chang, et al.
Publicado: (2023)

Isolation and characterization of stromal progenitor cells from ascites of patients with epithelial ovarian adenocarcinoma
por: Ho, Chih-Ming, et al.
Publicado: (2012)

Ascitic autotaxin as a potential prognostic, diagnostic, and therapeutic target for epithelial ovarian cancer
por: Choi, Jung-A, et al.
Publicado: (2023)

Immune environment and antigen specificity of the T cell receptor repertoire of malignant ascites in ovarian cancer
por: Yoshida-Court, Kyoko, et al.
Publicado: (2023)

Chryseobacterium indologenes peritonitis in a patient with malignant ascites
por: Wang, Yung-Chih, et al.
Publicado: (2011)

Ovarian epithelial cancer: a role for PGE(2)-synthesis and signalling in malignant transformation and progression
por: Rask, Katarina, et al.
Publicado: (2006)

Determination of the optimal volume of ascitic fluid for the precise diagnosis of malignant ascites
por: Zhang, Feifei, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_6gu7m9qmjeu9t64s48ib8cd36m